ATE189682T1 - Prohormonspaltungsplatzblockierungsantikörper - Google Patents

Prohormonspaltungsplatzblockierungsantikörper

Info

Publication number
ATE189682T1
ATE189682T1 AT90913016T AT90913016T ATE189682T1 AT E189682 T1 ATE189682 T1 AT E189682T1 AT 90913016 T AT90913016 T AT 90913016T AT 90913016 T AT90913016 T AT 90913016T AT E189682 T1 ATE189682 T1 AT E189682T1
Authority
AT
Austria
Prior art keywords
prohormone
blocking antibodies
place blocking
cleavage place
prohormone cleavage
Prior art date
Application number
AT90913016T
Other languages
English (en)
Inventor
Michael Kriegler
Carl Perez
Original Assignee
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiron Corp filed Critical Chiron Corp
Application granted granted Critical
Publication of ATE189682T1 publication Critical patent/ATE189682T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/241—Tumor Necrosis Factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y10S530/809—Fused cells, e.g. hybridoma

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Luminescent Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT90913016T 1989-08-16 1990-08-13 Prohormonspaltungsplatzblockierungsantikörper ATE189682T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39525489A 1989-08-16 1989-08-16
PCT/US1990/004536 WO1991002756A1 (en) 1989-08-16 1990-08-13 Prohormone cleavage site blocking antibody

Publications (1)

Publication Number Publication Date
ATE189682T1 true ATE189682T1 (de) 2000-02-15

Family

ID=23562288

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90913016T ATE189682T1 (de) 1989-08-16 1990-08-13 Prohormonspaltungsplatzblockierungsantikörper

Country Status (8)

Country Link
US (3) US5677182A (de)
EP (1) EP0487610B1 (de)
JP (1) JPH05501351A (de)
AT (1) ATE189682T1 (de)
AU (1) AU641178B2 (de)
CA (1) CA2023250A1 (de)
DE (1) DE69033457T2 (de)
WO (1) WO1991002756A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0614984T4 (da) * 1993-03-05 2010-12-20 Bayer Healthcare Llc Humane monoklonale anti-TNF-alfa-antistoffer
EP0657469A1 (de) * 1993-10-26 1995-06-14 Boehringer Ingelheim Pharmaceuticals Inc. L-Selektinspaltungsplatz, Verfahren zur Diagnose une ihre Verwendung
US6406901B1 (en) 1995-06-08 2002-06-18 Immunex Corporation TNF-a converting enzyme
US5830742A (en) * 1995-06-08 1998-11-03 Immunex Corporation TNF-α converting enzyme
IL122305A0 (en) * 1995-06-08 1998-04-05 Immunex Corp Tace polypeptide its production and its use
IL114461A0 (en) * 1995-07-05 1995-11-27 Yeda Res & Dev TNF modulation
CN1310675C (zh) * 1995-07-20 2007-04-18 依默耐克斯有限公司 TNF－α转变酶
US20060073141A1 (en) * 2001-06-28 2006-04-06 Domantis Limited Compositions and methods for treating inflammatory disorders
RU2377253C2 (ru) 2002-12-02 2009-12-27 Амген Фремонт,Инк. Антитела, специфичные к фактору некроза опухолей, и их применение
JP4769456B2 (ja) * 2004-12-27 2011-09-07 昭和シェル石油株式会社 ウレア系潤滑グリース組成物、転がり軸受けおよび電動パワーステアリング装置
SG182170A1 (en) 2007-06-06 2012-07-30 Domantis Ltd Polypeptides, antibody variable domains and antagonists
KR101806567B1 (ko) 2009-02-19 2018-01-10 메르츠 파마 게엠베하 운트 코. 카가아 매우 순수한 신경독을 제조하기 위한 수단 및 방법
WO2010124998A1 (en) * 2009-04-27 2010-11-04 Merz Pharma Gmbh & Co. Kgaa Means and methods for the determination of the amount of neurotoxin polypeptide and of its catalytic and proteolytic activities

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4474893A (en) * 1981-07-01 1984-10-02 The University of Texas System Cancer Center Recombinant monoclonal antibodies
US4870163A (en) * 1985-08-29 1989-09-26 New York Blood Center, Inc. Preparation of pure human tumor necrosis factor and hybridomas producing monoclonal antibodies to human tumor necrosis factor
DE3631229A1 (de) * 1986-09-13 1988-03-24 Basf Ag Monoklonale antikoerper gegen humanen tumornekrosefaktor (tnf) und deren verwendung
EP0288088B1 (de) * 1987-04-24 1994-03-09 Teijin Limited Bestimmung vom Tumornekrosefaktor; monoklonaler Antikörper und Zusammensetzung
WO1990000902A1 (en) * 1988-07-18 1990-02-08 Chiron Corporation Monoclonal antibodies reactive with cachectin
CA2064915C (en) * 1989-08-07 2001-05-29 Deborah A. Rathjen Tumour necrosis factor binding ligands

Also Published As

Publication number Publication date
DE69033457D1 (en) 2000-03-16
EP0487610A1 (de) 1992-06-03
CA2023250A1 (en) 1991-02-16
US5702705A (en) 1997-12-30
AU641178B2 (en) 1993-09-16
US5686259A (en) 1997-11-11
EP0487610B1 (de) 2000-02-09
DE69033457T2 (de) 2000-09-14
WO1991002756A1 (en) 1991-03-07
AU6276590A (en) 1991-04-03
JPH05501351A (ja) 1993-03-18
US5677182A (en) 1997-10-14

Similar Documents

Publication Publication Date Title
ATE189682T1 (de) Prohormonspaltungsplatzblockierungsantikörper
BR9710811A (pt) Fragmentos de liga-Æo de antigeno que detecta especificamente c-lulas cancerigenas nucleotideos que codificam os fragmentos e o seu uso para a profilaxia e detec-Æo de c-nceres
NO942850D0 (de)
ATE460946T1 (de) Gebrauch von bispezifischen antikörpern in diagnose und therapie
ATE267610T1 (de) Glykosylierte igg antikörper
ES2293973T3 (es) Anticuerpos anti-ccr2 humanizados y metodos de uso de los mismos.
NO913211L (no) Nytt monoklonalt antistoff mot nytt antigen knyttet til menneske-tumorer.
ES2156859T3 (es) Anticuerpos monoclonales y quimericos especificos para el factor de necrosis tumoral humano.
ATE177754T1 (de) Fragmente von prion proteinen.
ATE402192T1 (de) Anti-ccr4 antikörper und fragmente davon
CA2163032A1 (en) Antibody Fragments in Therapy
DK0540573T4 (da) Assay for frit- og kompleksbundet prostataspecifikt antigen (PSA)
Sandberg et al. Complement utilization by guinea pig γ1 and γ2 immunoglobulins through the C3 activator system
EP0265500A4 (de) Antikörper gegen menschlichen progesteronrezeptor sowie diagnosematerial und -verfahren.
EP0938505A4 (de) Monoklonale antikörper gegen endoglin und ihre verwendung in der antiangiogenen therapie
WO1999002545A3 (en) Antigen binding fragments, designated 4b5, that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers
ES2114064T3 (es) Inmunoanalisis para la deteccion de colageno o fragmentos de colageno.
AU6828387A (en) Assay for human breast cancer
IL93207A0 (en) A monoclonal antibody which binds to factor betaxiia and shows no substantial binding to factor xii
DE60029953D1 (de) Spezifische antikörper gegen humanes choriongonadotropin hormone und deren verwendung in therapie und diagnose
IT1264083B1 (it) Procedimento per la produzione in piante di anticorpi ingegnerizzati, anticorpi prodotti e loro uso in diagnosi e terapia.
NO168311C (no) Monoklonale antistoffer for humane ikke-smaacelle lungekarsinomer, cellelinjer som produserer disse samt diagnostisksett
ES2062762T3 (es) Metodo para tratar el choque septico.
Ablin Demonstration of intercellular and basement-membrane zone antibodies in benign prostatic hypertrophy
Parker et al. CA 125 and survival in ovarian cancer: preliminary communication